Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Science Signaling, American Association for the Advancement of Science (AAAS), Vol. 7, No. 315 ( 2014-03-04)
    Abstract: Signal transduction is a dynamic process that regulates cellular functions through multiple types of biomolecular interactions, such as the interactions between proteins and between proteins and nucleic acids. However, the techniques currently available for identifying protein-protein or protein–nucleic acid complexes typically provide information about the overall population of signaling complexes in a sample instead of information about the individual signaling complexes therein. We developed a technique called “microchannel for multiparameter analysis of proteins in a single complex” (mMAPS) that simultaneously detected individual target proteins either singly or in a multicomponent complex in cell or tissue lysates. We detected the target proteins labeled with fluorophores by flow proteometry, which provided quantified data in the form of multidimensional fluorescence plots. Using mMAPS, we quantified individual complexes of epidermal growth factor (EGF) with its receptor EGFR, EGFR with signal transducer and activator of transcription 3 (STAT3), and STAT3 with the acetylase p300 and DNA in lysates from cultured cells with and without treatment with EGF, as well as in lysates from tumor xenograft tissue. Consistent with the ability of this method to reveal the dynamics of signaling protein interactions, we observed that cells treated with EGF induced the interaction of EGF with EGFR and the autophosphorylation of EGFR, but this interaction decreased with longer treatment time. Thus, we expect that this technique may reveal new aspects of molecular interaction dynamics.
    Type of Medium: Online Resource
    ISSN: 1945-0877 , 1937-9145
    Language: English
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date: 2014
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    In: Cancer Cell, Elsevier BV, Vol. 23, No. 6 ( 2013-06), p. 796-810
    Type of Medium: Online Resource
    ISSN: 1535-6108
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2013
    detail.hit.zdb_id: 2074034-7
    detail.hit.zdb_id: 2078448-X
    SSG: 12
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    In: Journal of Clinical Investigation, American Society for Clinical Investigation, Vol. 125, No. 12 ( 2015-11-16), p. 4529-4543
    Type of Medium: Online Resource
    ISSN: 0021-9738 , 1558-8238
    Language: English
    Publisher: American Society for Clinical Investigation
    Publication Date: 2015
    detail.hit.zdb_id: 2018375-6
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    In: Nature Cancer, Springer Science and Business Media LLC, Vol. 3, No. 10 ( 2022-10-17), p. 1211-1227
    Abstract: Poly(ADP-ribose) polymerase (PARP) inhibitors have demonstrated promising clinical activity in multiple cancers. However, resistance to PARP inhibitors remains a substantial clinical challenge. In the present study, we report that anaplastic lymphoma kinase (ALK) directly phosphorylates CDK9 at tyrosine-19 to promote homologous recombination (HR) repair and PARP inhibitor resistance. Phospho-CDK9-Tyr19 increases its kinase activity and nuclear localization to stabilize positive transcriptional elongation factor b and activate polymerase II-dependent transcription of HR-repair genes. Conversely, ALK inhibition increases ubiquitination and degradation of CDK9 by Skp2, an E3 ligase. Notably, combination of US Food and Drug Administration-approved ALK and PARP inhibitors markedly reduce tumor growth and improve survival of mice in PARP inhibitor-/platinum-resistant tumor xenograft models. Using human tumor biospecimens, we further demonstrate that phosphorylated ALK (p-ALK) expression is associated with resistance to PARP inhibitors and positively correlated with p-Tyr19-CDK9 expression. Together, our findings support a biomarker-driven, combinatorial treatment strategy involving ALK and PARP inhibitors to induce synthetic lethality in PARP inhibitor-/platinum-resistant tumors with high p-ALK–p-Tyr19-CDK9 expression.
    Type of Medium: Online Resource
    ISSN: 2662-1347
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2022
    detail.hit.zdb_id: 3005299-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    Elsevier BV ; 2012
    In:  Journal of Biological Chemistry Vol. 287, No. 20 ( 2012-05), p. 16869-16879
    In: Journal of Biological Chemistry, Elsevier BV, Vol. 287, No. 20 ( 2012-05), p. 16869-16879
    Type of Medium: Online Resource
    ISSN: 0021-9258
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2012
    detail.hit.zdb_id: 2141744-1
    detail.hit.zdb_id: 1474604-9
    SSG: 12
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2011
    In:  Cancer Research Vol. 71, No. 8_Supplement ( 2011-04-15), p. 4051-4051
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 71, No. 8_Supplement ( 2011-04-15), p. 4051-4051
    Abstract: Receptor tyrosine kinases (RTKs), including insulin-like growth factor 1 receptor, cMet, fibroblast growth factor receptor, vascular endothelial growth factor receptor, and the four members of the epidermal growth factor receptor (EGFR) family, have been shown to localize in the nucleus. Among these, both EGFR/ErbB-1 and ErbB-2 have been shown to be involved in transcriptional regulation, cell proliferation, DNA repair, DNA replication, and chemo- and radio-resistance. Recent studies have demonstrated that endocytosis and endosomal sorting are involved in the nuclear transport of cell surface RTKs, such as EGFR and ErbB-2. However, how full-length receptors embedded in the endosomal membrane pass through the nuclear pore complexes (NPCs) and function as non-membrane-bound receptors in the nucleus remains unclear. Here, we demonstrate that membrane-embedded vesicular trafficking is involved in the nuclear transport of EGFR. Confocal immunofluorescence reveals that in response to EGF, a portion of EGFR redistributes to the Golgi and the endoplasmic reticulum (ER), where its NH2-terminus resides within the lumen of Golgi/ER and COOH-terminus is exposed to the cytoplasm. Blockage of the Golgi-to-ER retrograde trafficking by brefeldin A or dominant mutants of the small GTPase ADP-ribosylation factor, which both resulted in the disassembly of the coat protein complex I (COPI) coat to the Golgi, inhibit EGFR transport to the ER and the nucleus. We further find that EGF-dependent nuclear transport of EGFR is regulated by retrograde trafficking from the Golgi to the ER involving an association of EGFR with γ-COP, one of the subunits of the COPI coatomer. Our findings experimentally provide a comprehensive pathway that nuclear transport of EGFR is regulated by COPI-mediated vesicular trafficking from the Golgi to the ER. Furthermore, we show that upon EGF treatment, the biotinylated cell surface EGFR is trafficked to the inner nuclear membrane (INM) by INTERNET (integral trafficking from the endoplasmic reticulum to the nuclear envelope transport) through the NPCs, remaining in a membrane-bound environment. We then find that importin β regulates EGFR nuclear transport to the INM in addition to the nucleus/nucleoplasm (NP). Unexpectedly, the well-known endoplasmic reticulum associated translocon Sec61β is found to reside in the INM and associate with EGFR. Knocking down Sec61β expression reduces EGFR level in the NP portion and accumulates it in the INM portion. Thus, the Sec61β translocon plays an unrecognized role in the release of the membrane-anchored EGFR from the lipid bilayer of the INM to the nucleus. The newly identified Sec61β function provides an alternative pathway for nuclear transport that can be utilized by membrane-embedded proteins such as full-length EGFR and may serve as a general mechanism for other cell surface receptors. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 4051. doi:10.1158/1538-7445.AM2011-4051
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2011
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2013
    In:  Cancer Research Vol. 73, No. 8_Supplement ( 2013-04-15), p. 5169-5169
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 73, No. 8_Supplement ( 2013-04-15), p. 5169-5169
    Abstract: Signal transductions are critical for cell physiology functions and signaling complexes play major roles in carrying and delivering “signals. These processes occur mainly through protein-protein interaction (PPI) and protein-nucleic acid interaction (PNI). Conventional approaches are usually limited in identifying a specific cellular PPI, or PNI from large amount of a specific protein with limited relative quantification. However, multiple PPIs and PNIs actually occur within a single signaling complex in vivo in a dynamic manner and an effective methodology for accurately detecting these individual complexes for multiple targets are critical for further understanding the in depth mechanisms of cell signaling transduction. Herein we introduce a novel flow-proteometric technique named microchannel for Multi-parameters Analyzing Proteins in Single-complex (mMAPS), which integrates a microfluidics device into single-molecule spectroscopy with three different emission-wavelength detectors to directly detect and analyze each individual signaling complex. Briefly, proteins and/or nucleic acid were labeled by three separate wavelength fluorophores in individual complexes and each complex was examined when it flew through the detection spot in microchannel. Using this approach, we demonstrate various applications by analyzing multiple endogenous PPIs and PNIs in p53, EGFR, HER2, and NFκB complexes from cancer cell lines with the resolution of “single” signaling complex. For instance, using 50,000 cancer cells (HeLa) we have detected and quantified the interaction between three proteins including EGF, EGFR and STAT3. We identified the single protein complexes which contain all three targets (EGF/EGFR/STAT3) after EGF treatment for 30min. EGF/EGFR and EGFR/STAT3 were also been identified as well but we didn't identified EGF/STAT3 interaction. Interestingly, although 20% of detected EGFR were interacted with STAT3 after EGF stimulation, only 3% of EGFR found to interact with EGF in the EGFR complex. In addition, we have also detected the protein complexes containing both proteins and nucleic acid including endogenous p53, TBP1, and genomic DNA fragment and successfully identified p53, TBP1, and genomic DNA in a complex. Quantification results revealed that p53 and TBP1 interaction only occurred in the complexes with genomic DNA. In conclusion, mMAPS provides a powerful platform for direct investigating the composition of individual target protein complexes and reveals the actual quantitative results of specific PTMs, PPIs, and PNIs involved in the signaling complexes, which is important to dissect the detailed dynamics of signal transduction in vivo. Citation Format: Chao-Kai Chou, Heng-Huan Lee, Pei-Hsiang Tsou, Hirohito Yamaguchi, Ying-Nai Wang, Hong-Jen Lee, Jun Kameoka, Mien-Chie Hung. Flow-proteometric analysis of single signaling complex. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 5169. doi:10.1158/1538-7445.AM2013-5169
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2013
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    In: Molecular Cancer Therapeutics, American Association for Cancer Research (AACR), Vol. 10, No. 8 ( 2011-08-01), p. 1327-1336
    Abstract: Several antiangiogenic drugs targeting VEGF/VEGF receptor (VEGFR) that were approved by the Food and Drug Administration for many cancer types, including colorectal and lung cancer, can effectively reduce tumor growth. However, targeting the VEGF signaling pathway will probably influence the normal function of endothelial cells in maintaining homeostasis and can cause unwanted adverse effects. Indeed, emerging experimental evidence suggests that VEGF-targeting therapy induced less tumor cell–specific cytotoxicity, allowing residual cells to become more resistant and eventually develop a more malignant phenotype. We report an antitumor therapeutic EndoCD fusion protein developed by linking endostatin (Endo) to cytosine deaminase and uracil phosphoribosyltransferase (CD). Specifically, Endo possesses tumor antiangiogenesis activity that targets tumor endothelial cells, followed by CD, which converts the nontoxic prodrug 5-fluorocytosine (5-FC) to the cytotoxic antitumor drug 5-fluorouracil (5-FU) in the local tumor area. Moreover, selective targeting of tumor sites allows an increasing local intratumoral concentration of 5-FU, thus providing high levels of cytotoxic activity. We showed that treatment with EndoCD plus 5-FC, compared with bevacizumab plus 5-FU treatment, significantly increased the 5-FU concentration around tumor sites and suppressed tumor growth and metastasis in human breast and colorectal orthotropic animal models. In addition, in contrast to treatment with bevacizumab/5-FU, EndoCD/5-FC did not induce cardiotoxicity leading to heart failure in mice after long-term treatment. Our results showed that, compared with currently used antiangiogenic drugs, EndoCD possesses potent anticancer activity with virtually no toxic effects and does not increase tumor invasion or metastasis. Together, these findings suggest that EndoCD/5-FC could become an alternative option for future antiangiogenesis therapy. Mol Cancer Ther; 10(8); 1327–36. ©2011 AACR.
    Type of Medium: Online Resource
    ISSN: 1535-7163 , 1538-8514
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2011
    detail.hit.zdb_id: 2062135-8
    SSG: 12
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 75, No. 15_Supplement ( 2015-08-01), p. 5120-5120
    Abstract: Cellular signaling complexes, which are made up of mostly proteins and nucleic acids, play a major role in signal transduction by carrying and delivering messages that coordinate basic biological functions. These processes are mainly relayed through protein-protein and protein-nucleic acid interactions. Delineating the underlying mechanisms of cancer signal transduction, which is often deregulated, relies highly on the analysis of specific protein-protein and protein-nucleic acid interactions. Conventional methods for detecting protein-protein and protein-nucleic acid interactions mostly rely on cells collected from two-dimensional cell cultures, which are very different from the natural cellular environment in organs or tissues. Therefore, we developed a multiplex flow-proteometric platform that can analyze individual signaling complexes directly from tissue to enable us to accurately acquire the information on in vivo signal transduction. To demonstrate that single signaling complexes can be directly detected in lysates from fluorescent-labeled frozen tissue sections, we selected STAT3, p300, and genomic DNA as targets to detect and quantify individual complexes in xenograft tumor tissues. Endogenous STAT3 and p300 in frozen tumor tissue were immunolabeled with A488 and QD605, respectively, and with TOTO3 to label genomic DNA. All the detected events were presented in a 3D fluorescence plot, revealing seven different types of events. A minimal number of non-specific control IgG events were detected, and no interactions events were observed, indicating low background noise. Among all of the detected STAT3 events, on average 7.04% interacted with both p300 and genomic DNA in the same complex, 2.99% interacted with p300 only, and 15.23% interacted with DNA only. Thus, in the frozen xenograft tissue section, around 22% of STAT3 (15.23% STAT3−DNA + 7.04% STAT3−p300 −DNA) interacted with DNA and 7.04% of STAT3 interacted with p300 when bound on DNA to activate gene transcription. Looking at the data from the standpoint of p300, on average 5.88% of total p300 protein molecules interacted with STAT3 and genomic DNA, 2.5% with STAT3 only, and 3.06% with DNA only. All these data simultaneously obtained in each experiment not only identified STAT3, p300, and DNA in a single complex but also quantified the distribution of lone proteins and population complexes, which cannot be analyzed by conventional methods. Thus, we expect that this technique may reveal new aspects of molecular interaction in tissue. Citation Format: Chao-Kai Chou, Heng-Huan Lee, Pei-Hsiang Tsou, Chun-Te Chen, Jung-Mao Hsu, Hirohito Yamaguchi, Ying-Nai Wang, Jennifer L. Hsu, Jin-Fong Lee, Jun Kameoka, Mien-Chie Hung. Using flow-proteometric platform to analyze individual signaling complexes in tumor tissue. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 5120. doi:10.1158/1538-7445.AM2015-5120
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2015
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    In: Nature Communications, Springer Science and Business Media LLC, Vol. 7, No. 1 ( 2016-08-30)
    Abstract: Extracellular interaction between programmed death ligand-1 (PD-L1) and programmed cell death protein-1 (PD-1) leads to tumour-associated immune escape. Here we show that the immunosuppression activity of PD-L1 is stringently modulated by ubiquitination and N -glycosylation. We show that glycogen synthase kinase 3β (GSK3β) interacts with PD-L1 and induces phosphorylation-dependent proteasome degradation of PD-L1 by β-TrCP. In-depth analysis of PD-L1 N192, N200 and N219 glycosylation suggests that glycosylation antagonizes GSK3β binding. In this regard, only non-glycosylated PD-L1 forms a complex with GSK3β and β-TrCP. We also demonstrate that epidermal growth factor (EGF) stabilizes PD-L1 via GSK3β inactivation in basal-like breast cancer. Inhibition of EGF signalling by gefitinib destabilizes PD-L1, enhances antitumour T-cell immunity and therapeutic efficacy of PD-1 blockade in syngeneic mouse models. Together, our results link ubiquitination and glycosylation pathways to the stringent regulation of PD-L1, which could lead to potential therapeutic strategies to enhance cancer immune therapy efficacy.
    Type of Medium: Online Resource
    ISSN: 2041-1723
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2016
    detail.hit.zdb_id: 2553671-0
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages